Express Pharma

NOVEMBER 11, 2024

Purple Life Sciences, a company focused on harnessing natural ingredients for medical treatment, launched PSOCARE, a healing oil for psoriasis, at an event today. These products will blend natural compounds with advanced formulation technologies to provide natural, side-effect-free alternatives to conventional treatment methods.

Compounding 103

Compounding 103

STAT

OCTOBER 17, 2024

… Just a handful of networks of doctors, nurse practitioners, and physician assistants are writing prescriptions for dozens of websites offering the GLP-1 weight loss drugs, including the compounded versions that have been the subject of conflict and debate among clinicians and industry members , STAT reports.

Vaccines 243

Vaccines Compounding 243

STAT

OCTOBER 25, 2024

… A turbulent series of events surrounding the supply of Eli Lilly’s blockbuster weight loss treatment has raised concerns around how the U.S. By law, that should have prohibited compounding pharmacies from making copies of the drug, as they are allowed to do so only when the treatment is on the shortage list.

Compounding 225

Compounding Compounding Pharmacies Diabetes Drug Development 225

Pharma Marketing Network

JANUARY 16, 2025

Upcoming Informa Connect Events: Clinical Data Disclosure, Transparency and Plain Language Summaries February 25-26, 2025 Speaker Programs Summit March 3-5, 2025 Rare Disease Summit March 18-20, 2025 PAP Patient Assistance & Access Programs March 18-20, 2025 Hub and Specialty Pharmacy Models East March 18-20, 2025 Pharma Forum March 23-26, 2025 (..)

Specialty Pharmacies 40

Specialty Pharmacies Compounding Pharmacies Compounding 40

epicur

MARCH 12, 2024

Epicur Pharma’s Advisory Council member Ann Donoghue, DVM, MS shares her personal perspective on the important relationship between veterinary oncology and compounded medications used in chemotherapy treatments. But compounding is not easy, it requires skill, training, and consistency.

Compounding 52

Compounding Chemotherapy Compounding Pharmacies Labelling 52

Pharma Marketing Network

JANUARY 16, 2025

Upcoming Informa Connect Events: Clinical Data Disclosure, Transparency and Plain Language Summaries – February 25-26, 2025 Speaker Programs Summit – March 3-5, 2025 Rare Disease Summit – March 18-20, 2025 PAP Patient Assistance & Access Programs – March 18-20, 2025 Hub and Specialty Pharmacy Models East – March 18-20, (..)

Specialty Pharmacies 40

Specialty Pharmacies Compounding Pharmacies Compounding 40

National Association of Boards of Pharmacy

OCTOBER 16, 2024

On November 1, 2023, long-awaited revisions to the United States Pharmacopeia (USP) Chapters <795>: Pharmaceutical Compounding – Nonsterile Preparations and <797>: Pharmaceutical Compounding – Sterile Preparations became official. Chapters <795> and <797> present the standards for preparing compounded medications.

Compounding Pharmacies 45

Compounding Pharmacies Compounding 45

European Pharmaceutical Review

JANUARY 10, 2023

The novel macrocycle compound achieved high inhibiting concentrations in the lung airways of participants. Spexis’ novel macrocycle compound. In Part A of the trial, three single dose levels, 12.5mg, 25mg, and 50mg of the macrocycle compound were evaluated in four subjects per cohort. It targets the outer membrane of P.

Compounding 98

Compounding 98

pharmaphorum

MARCH 19, 2021

In doing so it’s compounded pre-existing pressure with pharma, where schedules are shrinking and policies are often already restrictive enough to build barriers for effective physician engagement. The threat of disease spread and other risk factors from COVID-19 have only compounded this. and Israel.

Compounding 141

Compounding Pharmaceutical Companies Pharmaceutical Companies Communication 141

Pharmacy Times

JANUARY 16, 2024

Although robotics can be instrumental in assuring sterility and reducing the overall number of potential hazardous drug exposure events, certain tasks require vigilant oversight.

Compounding Pharmacies 51

Compounding Pharmacies Compounding 51

European Pharmaceutical Review

AUGUST 17, 2022

Radioligand therapy (RLT), which combines a targeting compound (ligand) with a therapeutic radioactive atom (radioisotope), is an emerging treatment approach that may offer an alternative treatment option for some cancer patients. Healthcare professionals are asked to report any suspected adverse events. percent), dry mouth (38.8

Chemotherapy 122

Chemotherapy Labelling Compounding 122

pharmaphorum

MAY 5, 2021

Notably, the individuals recruited into the trial had PTSD stemming from a range of traumatic events, and had been having symptoms for an average of 14 years. Long-term, chronic PTSD – particularly when associated with depression and/or a history of alcohol or substance abuse, is regarded as much harder to treat.

Compounding 111

Compounding 111

LifeProNow

MARCH 20, 2023

Compounding that, nearly a third of patients who are newly diagnosed will have metastatic disease. Additionally, the darolutamide combination showed consistent benefits across clinically relevant secondary endpoints, with the overall incidence of treatment-emergent adverse events being similar between treatment arms.

Compounding 100

Compounding Pharmaceutical Companies Pharmaceutical Companies 100

Express Pharma

MARCH 21, 2024

The event had participation of more than 420 delegates, ~50 leaders from private and public sector, and drew patronage of more than 30 companies. Strategy, investing, and leadership for values-based growth were the pillars upon which the event stood, guiding participants through a labyrinth of opportunities and challenges.

Compounding 104

Compounding Pharmaceutical Companies Pharmaceutical Companies 104

pharmaphorum

AUGUST 2, 2022

The potential for ADCs to combine the best of both mAbs and small molecule drugs means that there has been high interest in developing a successful compound since the first successful clinical trial in 1983. Development of the compound was subsequently ended. Not all rosy.

Compounding 98

Compounding Drug Development 98

European Pharmaceutical Review

OCTOBER 25, 2024

The monoclonal antibody therapy was reported to be well tolerated, with most treatment emergent adverse events (TEAE) Grade 1 or 2, according to the findings. The compound was designed to address issues such as payload toxicity seen in first-generation ADC therapies, according to Zai Lab.

Chemotherapy 97

Chemotherapy Compounding Immunity Immunization 97

European Pharmaceutical Review

OCTOBER 17, 2022

Pluvicto combines a targeting compound (ligand, in this case directed to PSMA) with a therapeutic radioisotope (in this case lutetium-177). The most common adverse events (all grades) in the Pluvicto ® part of the study were fatigue, dry mouth, nausea, anaemia (low red blood cell counts), decreased appetite and constipation.

Chemotherapy 124

Chemotherapy Compounding 124

Compounding Pharmacy of America

JULY 6, 2022

However, any life event that pushes you to experience worry, fear, or uncertainty for prolonged periods can have negative impacts on your mental and physical health. The post Mental Effects of Stress: Learning to Relax in the Face of Everyday Stress appeared first on The Compounding Pharmacy of America.

Compounding Pharmacies 52

Compounding Pharmacies Compounding 52

European Pharmaceutical Review

JANUARY 23, 2023

This has been exacerbated by geopolitical events such as war, the energy crisis and high inflation rates. In addition, MSSG supports temporary national measures such as unit dose dispensing and compounding. Manufacturing delays and production capacity issues have led to supply problems affecting the majority of Member States.

Packaging 98

Packaging Labelling Compounding Communication 98

European Pharmaceutical Review

JULY 13, 2023

While this is essential in the interrogation of novel compounds for which we know very little about their efficacy and safety, it is also true that some biomedical research is highly wasteful. 3 Moreover, some studies have suggested that co-administration of these compounds can modulate the effects of one another at a receptor level.

Compounding 98

Compounding Drug Development Clinical Pharmacology Documentation 98

Eye on FDA

AUGUST 4, 2021

The reason they are included here is that they could be a factor in the need for fewer advisory committee meetings – if these candidate compounds are demonstrating promise that gets them more intensive oversight it may negate the need for outside counsel.

Clinical Pharmacology 122

Clinical Pharmacology Compounding Vaccines 122

European Pharmaceutical Review

OCTOBER 13, 2022

Astellas will present results from a Phase III clinical study evaluating fezolinetant, an investigational oral, non-hormonal compound being studied to potentially treat vasomotor symptoms (VMS) associated with menopause. Fezolinetant is designed as a selective neurokinin 3 (NK3) receptor antagonist.

Compounding 98

Compounding 98

PharmD Live

MAY 30, 2024

People over 65 make up only 14% of the population but account for 56% of hospitalizations for adverse drug events (ADEs) (Agency for Healthcare Research and Quality, AHRQ, 2021). The side effects can compound, resulting in a greater negative impact on a patient’s health than the individual effects of one medication alone.

Clinical Pharmacology 119

Clinical Pharmacology Hospitals Long-Term Care Facilities Dosage 119

Express Pharma

MARCH 24, 2023

Ivospemin (SBP-101) Ivospemin is a proprietary polyamine analogue designed to induce polyamine metabolic inhibition (PMI) by exploiting an observed high affinity of the compound for pancreatic ductal adenocarcinoma and other tumors.

Chemotherapy 94

Chemotherapy Compounding Diabetes 94

pharmaphorum

AUGUST 30, 2022

Once again, there was no significant observed increase in bleeding with asundexian at any dose or compared with placebo, backing up its safety, and according to the investigators the study was not large enough to detect a clinically meaningful reduction in cardiovascular events. BMS and J&J’s milvexian.

Compounding 98

Compounding 98

pharmaphorum

OCTOBER 7, 2022

View the full event guide here. With new technologies such as CryoEM and DNA encoded libraries showing promise, join us as we take a deep dive into the key challenges holding back the progression of candidates into pre-clinical studies by determining the best technologies and methodologies for your programs.

Medical Schools 52

Medical Schools Compounding Pharmaceutical Companies Pharmaceutical Companies 52

The Thyroid Pharmacist

JUNE 30, 2023

Interview With Dr. Mark Mandel To learn more, I decided to interview Dr. Mark Mandel, PharmD, compounding pharmacist, LDN expert, and fellow Midwestern University Chicago College of Pharmacy grad, on the effects of LDN in people with Hashimoto’s and autoimmunity. The transdermal formulation is recommended for children with autism.

Compounding 98

Compounding Immunity Immunization Compounding Pharmacies 98

pharmaphorum

OCTOBER 11, 2022

The Reuters Pharma event 2022 began as a bustling industry affair yesterday, based out of the Nice Acropolis convention centre on France’s balmy south coast. With speakers gathered from a broad range of departments across the sector, it was a day for listening and noting, but also exploring and even challenging.

Generic Medicine 98

Generic Medicine Compounding 98

Express Pharma

NOVEMBER 2, 2023

Against this backdrop, the CD drug sales across the eight-major markets (8MM*) are set to increase at a compound annual growth rate (CAGR) of 4.7 Additionally, this report analyses other significant industry forces and key events that will influence the market in the coming years. per cent from $9.5 billion in 2022 to $15.0

Biosimilars 100

Biosimilars Compounding 100

FDA Law Blog: Biosimilars

JULY 5, 2023

As a reminder, in Title I of the 2013 Drug Quality and Security Act (DQSA) (the Compounding Quality Act), Congress created the “outsourcing facility” FDA registration category, and set forth statutory parameters for their operation in new section 503B of the FDCA. 353b(a)(8). the wholesale distributor, repackager, relabeler). 2(d) at 9.

Compounding 52

Compounding Hospitals Labelling 52

pharmaphorum

JULY 22, 2022

An event that focuses on cleanroom technology in the pharmaceutical industry, the conference will serve to bridge that gap between the two areas while simultaneously providing a unique selling point. This event will look in-depth at the significant change that the cleanroom industry is going through. Event Hashtag: #PharmaCleanroom.

Compounding Pharmacies 52

Compounding Pharmacies Compounding 52

Express Pharma

JUNE 9, 2023

Professor Gray added, “In principle, there are a wide array of cancers and neurodegenerative diseases we can treat if we can understand how to manipulate alternative splicing events. We know that alternative splicing is highly relevant to disease, but there is a knowledge gap that must be addressed if we are to develop these drugs.

Compounding 98

Compounding 98

Eye on FDA

DECEMBER 10, 2020

Sometimes in the midst of events, perspective is elusive. Usually prior to an FDA Advisory Committee meeting where a product is being considered for approval, the posting of the FDA Reviewer comments is greatly anticipated for what it will say about the potential shortcomings of the investigative compound under consideration.

Vaccines 97

Vaccines Compounding Hospitals 97

pharmaphorum

NOVEMBER 9, 2020

In a joint statement the World Federation of Hemophilia, the European Haemophilia Consortium and the National Hemophilia Foundation said Sanofi had voluntary put the full development programme on hold “due to the identification of new adverse events”.

Compounding 52

Compounding 52

Pharmaceutical Technology

APRIL 4, 2023

Ivospemin is a subcutaneously administered polyamine analogue being developed by Panbela to induce polyamine metabolic inhibition (PMI) through the exploitation of an observed high affinity of the compound for pancreatic ductal adenocarcinoma and other tumours.

Chemotherapy 59

Chemotherapy Compounding 59

epicur

AUGUST 8, 2023

Implementation of GFI #256 Earlier this year, the FDA finalized regulatory guidance for compounded medications, known as GFI #256. If GFI is affecting your practice’s ability to get compounded medications for office use, partnering with a trusted 503B outsourcing facility can help you eliminate risks of limited ordering.

Compounding 52

Compounding Documentation Compounding Pharmacies Packaging 52

pharmaphorum

FEBRUARY 3, 2022

As Part of Europe’s leading Injectable conference series, we will assess innovations in drug product formulation and biologics, new technologies in device design and the use of long-release injectable compounds. The injectable drug delivery market is expected to rise at a compound annual growth rate of 12.9%

Compounding 52

Compounding Packaging Biosimilars Vaccines 52